Human Gene Therapy · 2022 · 13 citations · 17 references
Life SciencesEndocrinologyMolecular GeneticsCellular MetabolismGene TherapySteroid BiochemistryAdrenal DisordersAdrenal SteroidogenesisCytochrome P450-mediated MetabolismSteroid BiosynthesisSteroid MetabolismSteroid Metabolism Disorders11 Beta-hydroxylase11-Beta-hydroxylase Deficiency11Beta-hydroxylase Deficiency17, 20-LyaseAdeno-associated Viral TransgenesisSteroidogenic DefectsSteroidogenic Enzyme DefectsSteroidogenic Enzyme Deficiency
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by steroidogenic enzymes containing monogenetic defects. Most steroidogenic enzymes are cytochrome P450 groups that can be categorized as microsomal P450s, including 21-hydroxylase and 17α-hydroxylase/17,20 lyase, and mitochondrial P450s, including 11β-hydroxylase. It has been shown that ectopic administration of Cyp21a1 ameliorates steroid metabolism in 21-hydroxylase-deficient mice. However, the effectiveness of this approach for mitochondrial P450 has not yet been evaluated. In this study, primary fibroblasts from patients with 21-hydroxylase deficiency (CYP21A2D) ( n = 4), 17α-hydroxylase/17,20 lyase deficiency (CYP17A1D) ( n = 1), and 11β-hydroxylase deficiency (CYP11B1D) ( n = 1) were infected with adeno-associated virus type 2 (AAV2) vectors. Steroidogenic enzymatic activity was not detected in the AAV2-infected CYP11B1D fibroblasts. Induced pluripotent stem cells (iPSCs) of CYP11B1D were established and differentiated into adrenocortical cells by induction of the NR5A1 gene. Adrenocortical cells established from iPSCs of CYP11B1D (CYP11B1D-iPSCs) were infected with an AAV type 9 (AAV9) vector containing CYP11B1 and exhibited 11β-hydroxylase activity. For an in vivo evaluation, we knocked out Cyp11b1 in mice by using the CRISPR/Cas9 method. Direct injection of Cyp11b1 -containing AAV9 vectors into the adrenal gland of Cyp11b1 -deficient mice significantly reduced serum 11-deoxycorticosterone/corticosterone ratios at 4 weeks after injection and the effect was prolonged for up to 12 months. This study indicated that CYP11B1D could be ameliorated by gene induction in the adrenal glands, which suggests that a defective-enzyme-dependent therapeutic strategy for CAH would be required. Defects in microsomal P450, including CYP21A2D and CYP17A1D, can be treated with extra-adrenal gene induction. However, defects in mitochondrial P450, as represented by CYP11B1D, may require adrenal gene induction.
17
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jínek, Krzysztof Chylinski, Ines Fonfara et al. · Science · 2012 · 17.3K citations · Full text
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali, Luhan Yang, Kevin M. Esvelt et al. · Science · 2013 · 9.4K citations · Full text
Phyllis Speiser, Wiebke Arlt, Richard J. Auchus et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 1.2K citations · Full text
Medicine, Endocrinology, Pediatrics +17